Brief: Idorsia Reports Daridorexant Results In A Phase 2 Study In Children With Insomnia Disorder
30/03/2026 06:03
March 30 (Reuters) - IDORSIA LTD IDIA.S: IDORSIA’S DARIDOREXANT DELIVERS OUTSTANDING RESULTS IN A PHASE 2 STUDY IN CHILDREN WITH INSOMNIA DISORDER PHASE 2 SHOWS SIGNIFICANT DOSE-DEPENDENT IMPROVEMENT IN SLEEP FOR CHILDREN WITH INSOMNIA Source text: ID:nGNEc7Zgxg Further company coverage: IDIA.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))